Open Access

Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol

Event: ESC CONGRESS 2017
Topic: Atherosclerosis
Session type: Satellite Symposium
Sponsored by Novartis Pharma AG
Date: 28 August 2017
Time: 12:45 - 13:45

Session

7 presentations in this session

Welcome - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Speaker: Professor T. Luscher (London, GB)
Thumbnail

Atherosclerosis and the cardiovascular continuum.

Speaker: Professor P. Libby (Boston, US)
Thumbnail

What are the unmet medical needs in secondary cardiovascular disease prevention?

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

Cardiovascular residual risk: what are the markers?

Speaker: Professor W. Koenig (Munich, DE)
Thumbnail

Secondary cardiovascular disease prevention: what have we learnt from recent clinical trials?

Speaker: Doctor P. Ridker (Boston, US)
Thumbnail

Audience Q&A and panel discussion - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Speaker: Professor P. Libby (Boston, US)
Thumbnail

Summary and closing remarks - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Speaker: Professor T. Luscher (London, GB)
Thumbnail

7 speakers from this session

Professor Thomas Felix Luscher

Royal Brompton and Harefield Hospital, London (United Kingdom of Great Britain & Northern Ireland)
33 presentations
0 follower

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
28 presentations
2 followers

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
44 presentations
2 followers

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
20 presentations
0 follower

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
25 presentations
2 followers

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
28 presentations
2 followers

Professor Thomas Felix Luscher

Royal Brompton and Harefield Hospital, London (United Kingdom of Great Britain & Northern Ireland)
33 presentations
0 follower

This platform is supported by

logo Novo Nordisk